NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-113-2021-0-GB-01 BACTERIOPHAGE LAMBDA-VACCINE SYSTEM GB EP 22847091.0 Issued
NCI E-113-2021-0-DE-01 BACTERIOPHAGE LAMBDA-VACCINE SYSTEM DE EP 22847091.0 Issued
NCI E-113-2021-0-FR-01 BACTERIOPHAGE LAMBDA-VACCINE SYSTEM FR EP 22847091.0 Issued
NIAID E-118-2023-2-PC-01 VACCINE FOR CATS TO BLOCK TOXOPLASMA OOCYST SHEDDING AND TRANSMISSION PCT PCT PCT/US2024/032292 Expired
NICHD E-131-2023-0-US-02 Additional fusion proteins combining matrilin-3-binding antibody fragments and IGF-1 US 63/654,777 Expired
NICHD E-131-2023-0-US-01 Additional fusion proteins combining matrilin-3-binding antibody fragments and IGF-1 US 63/654,790 Expired
NICHD E-131-2023-0-US-03 Additional fusion proteins combining matrilin-3-binding antibody fragments and IGF-1 US 63/654,780 Expired
NICHD E-184-2021-0-MX-01 LEVONORGESTREL BUTANOATE FORMULATION AND METHODS RELATING THERETO MX National Stage MX/a/2024/006735 Pending
NCI E-205-2021-0-KR-01 IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 (GPC3) AND USE THEREOF KR National Stage 10-2024-7018383 Pending
NIAID E-169-2023-0-PC-01 HIV-1 ENVELOPE TRIPLE TANDEM TRIMERS AND THEIR USE PCT PCT PCT/US2024/031661 Expired
NIAID E-025-2024-0-US-01 Pan-GI norovirus monoclonal antibody 16E10 and its use US 63/653,691 Expired
NICHD E-184-2021-0-SG-01 LEVONORGESTREL BUTANOATE FORMULATION AND METHODS RELATING THERETO SG National Stage 11202403735R Pending
NCI E-199-2021-0-US-02 COMPOSITIONS FOR INHIBITING DIPEPTIDE REPEAT PROTEIN-RIBOSOMAL RNA INTERACTION AND USES THEREOF US National Stage 18/714,298 Pending
NIAID E-208-2023-0-JP-01 HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES JP National Stage 2024-532181 Pending
NICHD E-184-2021-0-BR-01 LEVONORGESTREL BUTANOATE FORMULATION AND METHODS RELATING THERETO BR National Stage BR112024010771-0 Pending
NIAAA E-190-2021-0-IL-01 Thiol-moeity Containing Cannabinoid Receptor Modulating Compounds IL National Stage 313211 Abandoned
NCI E-217-2023-0-US-01 DRUG-REGULATABLE, INDUCIBLE CYTOKINE EXPRESSION US 63/652,871 Expired
NIDCR E-011-2023-0-PCT-01 COPIPARVOVIRUS GENETIC VECTOR PLATFORM PCT PCT PCT/US2024/031301 Expired
NIAID E-208-2023-0-CA-01 HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES CA National Stage 3239461 Pending
NIAID E-208-2023-0-MX-01 HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES MX National Stage MX/a/2024/006506 Pending
NIAID E-004-2009-2-US-29 VIRUS LIKE PARTICLE COMPOSITIONS AND METHODS OF USE US DIV 18/675,059 12281336 Issued PDF
NIAID E-021-2019-0-US-02 CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN US CON 18/675,033 Pending
NCI E-040-2022-0-US-01 METHODS FOR TREATING BILE DUCT CANCERS WITH TIVOZANIB US National Stage 18/713,533 Pending
NIAID E-208-2023-0-CN-01 HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES CN National Stage 202280078145.6 Pending
NIBIB E-168-2021-2-EP-01 SYSTEMS AND METHODS FOR THREE-DIMENSIONAL STRUCTURED ILLUMINATION MICROSCOPY WITH ISOTROPIC SPATIAL RESOLUTION EP National Stage 22890944.6 Abandoned
NCI E-219-2021-0-US-02 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION US National Stage 18/713,490 Pending
NEI E-116-2023-0-PC-01 TYROSINASE GENE THERAPY FOR OCULOCUTANEOUS ALBINISM TYPE 1A PCT PCT PCT/US2024/031101 Expired
NIAID E-208-2023-0-SG-01 HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES SG National Stage 11202403543R Pending
NCI E-201-2023-0-US-01 QUANTITATIVE PARTICLE IDENTIFICATION DIGITAL AUTORADIOGRAPHY US 63/651,184 Expired
NHLBI E-146-2023-0-EP-01 ANTIBODIES TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF EP ORD 24177638.4 Abandoned
NIAID E-014-2023-0-PC-01 HUMAN MONOCLONAL ANTIBODIES THAT TARGET THE RH5 COMPLEX OF BLOOD-STAGE PLASMODIUM FALCIPARUM PCT PCT PCT/US2024/030637 Expired
NIAID E-208-2023-0-US-02 HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES US National Stage 18/671,660 Pending
NCI E-099-2023-1-PC-01 T CELL RECEPTORS (TCRS) GENERATED AS A RESULT OF HPV VACCINE THERAPY AND METHODS OF TREATING PATIENTS WITH SAME PCT PCT PCT/US2024/030357 Expired
NIAID E-055-2024-0-PC-01 METHODS FOR TREATING LUNG DISEASES AND DISORDERS PCT PCT PCT/US2024/030429 Pending
NIAID E-205-2024-2-US-01 Human Protective Neutralizing and Non-Neutralizing Antibodies and Their Use Against Influenza Viruses US 63/650,342 Expired
NIAID E-240-2020-0-PC-01 RECOMBINANT MURINE PNEUMONIA VIRUS EXPRESSING SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE PROTEIN PCT PCT PCT/US2024/029917 Expired
NCI E-033-2022-0-EP-01 ANTI-MESOTHELIN POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS EP National Stage 22854336.9 Pending
NCI E-042-2014-0-KR-01 Chimeric Antigen Receptors Targeting CD-19 KR DIV 10-2024-7016401 Pending
NCI E-205-2021-0-EP-01 IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 (GPC3) AND USE THEREOF EP National Stage 22821820.2 Pending
NCI E-033-2022-0-US-02 ANTI-MESOTHELIN POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS US National Stage 18/710,726 Pending
NIAID E-238-2020-0-US-03 EXPRESSION OF THE SPIKE S GLYCOPROTEIN OF SARS-COV-2 FROM AVIAN PARAMYXOVIRUS TYPE 3 (APMV3) US National Stage 18/710,343 Pending
NIAID E-241-2014-0-US-03 RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 3 (B/HPIV3) EXPRESSING A CHIMERIC RSV/PIV3 F PROTEIN AND USES THEREOF US CON 18/665,309 Pending
NCI E-219-2021-0-EP-01 HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION EP National Stage 22844381.8 Pending
NEI E-077-2018-0-US-02 METHODS OF METABOLIC REGULATION OF MITOCHONDRIA FOR TREATING NEURAL INJURY AND NEUROLOGICAL DISORDERS US CON 18/664,615 Abandoned
NHLBI E-105-2024-0-US-01 SYSTEMS AND METHODS FOR A TEMPORARY AORTIC VALVE COUNTERPULSATION CATHETER US 63/648,029 Expired
NIAID E-193-2022-0-US-01 HUMAN MONOCLONAL ANTIBODIES THAT TARGET TERMINAL ALPHA-GAL MOIETIES ON VECTOR-BORNE PATHOGENS AND UNRESECTABLE SOLID TUMORS US 63/647,859 Expired
NCI E-234-2014-1-IL-03 METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF IL DIV 312867 Pending
NIAID E-208-2023-0-IN-01 HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES IN National Stage 202417038257 Pending
NCI E-244-2015-0-US-23 BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE US DIV 18/664,031 Pending
NCI E-021-2015-0-US-02 ANTI-CD70 CHIMERIC ANTIGEN RECEPTORS US DIV 18/663,557 Pending